Market Overview

Aimmune Therapeutics (NASDAQ: AIMT)

27.57 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/05/18Credit SuisseMaintainsOutperform47.0
2/07/18RBC CapitalInitiates Coverage OnOutperform55.0
12/20/17BairdInitiates Coverage OnOutperform64.0
12/13/17Cantor FitzgeraldInitiates Coverage OnOverweight55.0
10/23/17Credit SuisseMaintainsOutperform45.0
3/07/16Credit SuisseMaintainsOutperform35.0
3/01/16WedbushInitiates Coverage onOutperform42.0
1/22/16Credit SuisseMaintainsOutperform44.0
8/31/15Credit SuisseInitiates Coverage onOutperform44.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter